Equity Overview
Price & Market Data
Price: $0.821
Daily Change: +$0.0281 / 3.42%
Daily Range: $0.821 - $0.821
Market Cap: $10,342,685
Daily Volume: 333
Performance Metrics
1 Week: 3.54%
1 Month: -7.27%
3 Months: -11.32%
6 Months: 6.64%
1 Year: 44.19%
YTD: -7.27%
Company Details
Employees: 23
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.